IMPACT OF LOW BIRTH WEIGHT AND PREMATURITY ON NEONATAL RALTEGRAVIR PHARMACOKINETICS: IMPAACT P1097

BACKGROUND. HIV treatment of neonates requires identifying appropriate antiretroviral dosing regimens. Our aims were to characterize raltegravir elimination kinetics in low birth weight (LBW) neonates after maternal dosing and to develop a pharmacokinetic model to predict raltegravir plasma concentr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Acquir Immune Defic Syndr
Auteurs principaux: Clarke, Diana F., Lommerse, Jos, Acosta, Edward P., Cababasay, Mae P., Wang, Jiajia, Spector, Stephen A., Chain, Anne, Smith, Elizabeth, Teppler, Hedy, Hazra, Rohan, Calabrese, Kat, Graham, Bobbie, Popson, Stephanie, Bryson, Yvonne, Mirochnick, Mark
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043209/
https://ncbi.nlm.nih.gov/pubmed/32925360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002492
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires